The initial step is to seek the services of a licensed healthcare professional who is in a position to assess your medical background, current health status, and weight loss objectives in order to recommend the best type of injection
more pronounced improvement was observed in sociability and repetitive behavior of female rats of environmentally induced ASD with maternal immune activation (MIA)-induced ASD and mice with prenatal valproic acid exposure-induced ASD [167]
,
To Qualify for Consideration: By August 31st, 2024, submit an abstract for oral or poster Presentation where they are listed as the lead presenter
GLP-1 receptor agonists Primary mechanism(s) of action Increase glucose-dependent insulin secretion, reduce post-prandial glucagon, and delay gastric emptying (resulting in reduced after meal glucose levels and increased satiety) Examples Exenatide (Byetta 10 mcg Pen, Byetta 5 mcg Pen, Bydureon BCise 2 mcg Pen) Dosage Immediate release (Byetta) Initial: 5 mcg subcutaneous injection twice daily a maximum of 60 minutes before morning and evening meals, or before the two main meals of the day Maximum: 10 mcg subcutaneous injection twice daily a maximum of 60 minutes before morning and evening meals, or before the two main meals of the day Extended release (Bydureon BCise) Initial: 2 mg subcutaneous injection once weekly Maximum: 2 mg subcutaneous injection weekly Lixisenatide (Adlyxin) Short-acting Dosage Initial: 10 mcg subcutaneous injection once daily, up to one hour before the first meal of the day, for 14 days
